5-chloro-N-(4-(N-hydroxysulfamoyl)phenethyl)-2-methoxybenzamide

ID: ALA4583133

Cas Number: 2112809-98-8

PubChem CID: 134600183

Product Number: J648756, Order Now?

Max Phase: Preclinical

Molecular Formula: C16H17ClN2O5S

Molecular Weight: 384.84

Molecule Type: Unknown

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NO)cc1

Standard InChI:  InChI=1S/C16H17ClN2O5S/c1-24-15-7-4-12(17)10-14(15)16(20)18-9-8-11-2-5-13(6-3-11)25(22,23)19-21/h2-7,10,19,21H,8-9H2,1H3,(H,18,20)

Standard InChI Key:  KQRQPMUPYDOTCA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
   13.9748   -5.9721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3875   -6.6820    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.7959   -5.9696    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0969   -7.0912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6815   -7.0901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9785   -6.6818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2730   -7.0893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2730   -7.9056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9844   -8.3128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6870   -7.9031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5660   -8.3155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0972   -7.9084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8575   -7.9082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1506   -8.3181    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4421   -7.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7352   -8.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4406   -7.0936    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0283   -7.9089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3219   -8.3181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3229   -9.1362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0364   -9.5433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7399   -9.1318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4500   -9.5363    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4547  -10.3535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6136   -7.9105    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  2  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
  4 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 16  1  0
 22 23  1  0
 23 24  1  0
 19 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4583133

    JC-171

Associated Targets(non-human)

Nlrp3 NACHT, LRR and PYD domains-containing protein 3 (641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.84Molecular Weight (Monoisotopic): 384.0547AlogP: 1.99#Rotatable Bonds: 7
Polar Surface Area: 104.73Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.20CX Basic pKa: CX LogP: 2.11CX LogD: 2.10
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.63Np Likeness Score: -1.13

References

1. Zhang X, Xu A, Lv J, Zhang Q, Ran Y, Wei C, Wu J..  (2020)  Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.,  185  [PMID:31699536] [10.1016/j.ejmech.2019.111822]
2. Zhang C, Yue H, Sun P, Hua L, Liang S, Ou Y, Wu D, Wu X, Chen H, Hao Y, Hu W, Yang Z..  (2021)  Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities.,  219  [PMID:33845232] [10.1016/j.ejmech.2021.113417]

Source